Transcode Therapeutics, Inc. - COM NEW (RNAZ)

Historical Portfolio Holders from Q4 2023 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q3 2024
325K
Holdings value Q3 2024
$186K
Value change Q3 2024
-$31.6K
Grand Portfolio weight change Q3 2024
0%
Number of holders
9
Number of buys Q3 2024
7
Number of sells Q3 2024
-8
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 325K $186K -$31.6K $0.57 9
2024 Q2 262K $263K -$47K $1.01 14
2024 Q1 417K $284K +$276K $0.68 6
2023 Q4 50K $8.24K +$8.24K $0.16 1